Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China.
Centre de Recherche Institut Universitaire de Cardiologie & Pneumologie de Québec, Université Laval, Québec City, G1V 4G5, Canada.
Hum Mol Genet. 2017 Dec 15;26(24):4814-4822. doi: 10.1093/hmg/ddx360.
Mutations in FBN1 have been well identified in syndromic aortic dissection (AD) and familial thoracic aortic aneurysms and dissections. However, whether mutations of FBN1 contribute to sporadic non-syndromic AD and the characteristics of mutations remain unknown. Using next-generation-sequencing technology, FBN1 was sequenced in a total of 702 sporadic cases (including 687 of non-syndromic AD and 15 of sporadic Marfan syndrome with aortic event, and 527 normal controls). For the sporadic non-syndromic AD cohort, we found 26 variants in 27 patients (18 with missense, 2 frameshift, 1 initiation codon mutation, 3 nonsense and 3 splice site mutations). The prevalence of variants was significantly high in the sporadic non-syndromic AD cohort (27/687, 3.9%). The patients with FBN1 mutations were younger, suffered from fewer risk factors such as hypertension and smoking, and were less gender partitioned than non-FBN1-mutation AD patients. The mutations were spread along the FBN1 gene in our sporadic non-syndromic AD cohort and mutation locations are not different between non-syndromic and syndromic patients. These results demonstrate that the deleterious mutations in FBN1 largely contribute to pathogenesis of sporadic non-syndromic AD, which expands our knowledge of FBN1 variants and the genetic basis and pathology of AD.
FBN1 基因突变已在综合征型主动脉夹层 (AD) 和家族性胸主动脉瘤和夹层中得到很好的鉴定。然而,FBN1 的突变是否导致散发性非综合征型 AD 以及突变的特征仍不清楚。使用下一代测序技术,对总共 702 例散发性病例(包括 687 例非综合征型 AD、15 例散发性马凡综合征伴主动脉事件和 527 例正常对照)进行了 FBN1 测序。对于散发性非综合征型 AD 队列,我们在 27 名患者中发现了 26 种变异(18 种错义变异、2 种移码变异、1 种起始密码子突变、3 种无义突变和 3 种剪接位点突变)。变异在散发性非综合征型 AD 队列中的发生率明显较高(27/687,3.9%)。携带 FBN1 突变的患者更年轻,患高血压和吸烟等危险因素的比例较低,且性别分布较非 FBN1 突变 AD 患者更为均衡。突变在我们的散发性非综合征型 AD 队列中沿 FBN1 基因分布,且非综合征型和综合征型患者的突变位置无差异。这些结果表明,FBN1 中的有害突变在很大程度上导致了散发性非综合征型 AD 的发病机制,这扩展了我们对 FBN1 变体以及 AD 的遗传基础和病理学的认识。